Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Courtney V Fletcher

Showing results (11-20 of 162) with videos related to

Pageof 17
Sort By:
Journal of Pharmaceutical and Biomedical Analysis|June 26, 2012
A novel ultrasensitive LC-MS/MS assay for quantification of intracellular raltegravir in human cell extractsBrian L Robbins, Sarah R Nelson, Courtney V Fletcher
Frontiers in Immunology|July 1, 2026
Cloning and expression of natively paired antibody fragments from single B cells of immunized rhesus macaquesJohid Reza Malik, Courtney V Fletcher, Sean N Avedissian
Antimicrobial Agents and Chemotherapy|September 8, 2011
Plasma and intracellular population pharmacokinetic analysis of tenofovir in HIV-1-infected patientsGautam Baheti, Jennifer J Kiser, Peter L Havens, et al.
Current Opinion in HIV and AIDS|March 5, 2013
Overcoming pharmacologic sanctuariesTheodore J Cory, Timothy W Schacker, Mario Stevenson, et al.
Clinical Pharmacology and Therapeutics|March 25, 2021
The Contributions of Clinical Pharmacology to HIV Cure ResearchCourtney V Fletcher, Shetty Ravi Dyavar, Arpan Acharya, et al.
Pharmacotherapy|May 28, 2008
Successful use of reduced-dose efavirenz in a patient with human immunodeficiency virus infection: case report and review of the literatureMauro S Torno, Mallory D Witt, Akihiko Saitoh, et al.
AIDS (London, England)|October 3, 2003
Antiviral dynamics and sex differences of zidovudine and lamivudine triphosphate concentrations in HIV-infected individualsPeter L Anderson, Thomas N Kakuda, Sagar Kawle, et al.
AIDS (London, England)|October 4, 2012
Age-related differences in plasma and intracellular tenofovir concentrations in HIV-1-infected children, adolescents and adultsGautam Baheti, Jennifer R King, Edward P Acosta, et al.
Pharmacotherapy|March 7, 2012
Acceptable plasma concentrations of raltegravir and etravirine when administered by gastrostomy tube in a patient with advanced multidrug-resistant human immunodeficiency virus infectionUriel Sandkovsky, Susan Swindells, Ryan Moore, et al.
Antimicrobial Agents and Chemotherapy|September 26, 2007
Impact of nucleoside reverse transcriptase inhibitors on mitochondria in human immunodeficiency virus type 1-infected children receiving highly active antiretroviral therapyAkihiko Saitoh, Terence Fenton, Carmelita Alvero, et al.
Pageof 17

Showing results (11-20 of 162) with videos related to

Sort By:
Pageof 17
Journal of Pharmaceutical and Biomedical Analysis|June 26, 2012
A novel ultrasensitive LC-MS/MS assay for quantification of intracellular raltegravir in human cell extractsBrian L Robbins, Sarah R Nelson, Courtney V Fletcher
Frontiers in Immunology|July 1, 2026
Cloning and expression of natively paired antibody fragments from single B cells of immunized rhesus macaquesJohid Reza Malik, Courtney V Fletcher, Sean N Avedissian
Antimicrobial Agents and Chemotherapy|September 8, 2011
Plasma and intracellular population pharmacokinetic analysis of tenofovir in HIV-1-infected patientsGautam Baheti, Jennifer J Kiser, Peter L Havens, et al.
Current Opinion in HIV and AIDS|March 5, 2013
Overcoming pharmacologic sanctuariesTheodore J Cory, Timothy W Schacker, Mario Stevenson, et al.
Clinical Pharmacology and Therapeutics|March 25, 2021
The Contributions of Clinical Pharmacology to HIV Cure ResearchCourtney V Fletcher, Shetty Ravi Dyavar, Arpan Acharya, et al.
Pharmacotherapy|May 28, 2008
Successful use of reduced-dose efavirenz in a patient with human immunodeficiency virus infection: case report and review of the literatureMauro S Torno, Mallory D Witt, Akihiko Saitoh, et al.
AIDS (London, England)|October 3, 2003
Antiviral dynamics and sex differences of zidovudine and lamivudine triphosphate concentrations in HIV-infected individualsPeter L Anderson, Thomas N Kakuda, Sagar Kawle, et al.
AIDS (London, England)|October 4, 2012
Age-related differences in plasma and intracellular tenofovir concentrations in HIV-1-infected children, adolescents and adultsGautam Baheti, Jennifer R King, Edward P Acosta, et al.
Pharmacotherapy|March 7, 2012
Acceptable plasma concentrations of raltegravir and etravirine when administered by gastrostomy tube in a patient with advanced multidrug-resistant human immunodeficiency virus infectionUriel Sandkovsky, Susan Swindells, Ryan Moore, et al.
Antimicrobial Agents and Chemotherapy|September 26, 2007
Impact of nucleoside reverse transcriptase inhibitors on mitochondria in human immunodeficiency virus type 1-infected children receiving highly active antiretroviral therapyAkihiko Saitoh, Terence Fenton, Carmelita Alvero, et al.
Pageof 17